Haemonetics Corporation is a global healthcare company that specializes in blood management solutions. The company focuses on providing innovative medical devices and software solutions for blood and plasma collection, as well as blood processing and transfusion services. Haemonetics aims to improve the quality and safety of the blood supply, enhance clinical outcomes, and reduce healthcare costs.

Haemonetics Vascular Closure

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Haemonetics

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

COM:HAEMONETICS

Haemonetics Corporation

Last Close

75.38

30/08 20:00

Market Cap

3.87B

Beta: -

Volume Today

583.13K

Avg: -

Analysis Not Available